ABVC Stock Analysis: Buy, Sell, or Hold?
ABVC - ABVC BioPharma, Inc. Common Stock
$1.80
0.03 (1.69%)
▲
5d:
+24.14%
30d:
+44.0%
90d:
+66.67%
WAIT
LOW Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When ABVC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: ABVC is 17.6% above its trading range ($1.53). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: ABVC is 17.6% above its trading range ($1.53). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: ABVC is currently trading at $1.80, which is considered extended relative to its 30-day fair value range of $1.25 to $1.53.
Technical Outlook: Technically, ABVC is showing sideways momentum. The price is approaching resistance at $1.84. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ABVC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.02 (+12.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ABVC is showing sideways momentum. The price is approaching resistance at $1.84. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ABVC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.02 (+12.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.25 -
$1.53
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
50.0%
All Signals
- BEARISH: Price significantly overextended (+17.6% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($2.02)
- WARNING: Recommendation downgraded due to 17.6% overvaluation
Trading Range Analysis
30-Day Trading Range
$1.25 -
$1.53
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.28
Resistance Level
$1.84
Current Trend
Sideways
Technical data as of
Jul 2, 2026
Fundamental Context
Wall Street Target
$2.02
(+12.2%)
Revenue Growth (YoY)
104.5%
Share & Embed Analysis
Last updated: July 02, 2026 10:32 PM ET
Data refreshes hourly during market hours. Next update: 11:32 PM
Data refreshes hourly during market hours. Next update: 11:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABVC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 59 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 56 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$34 | 67 BUY |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
